# TEIRV Implementation Checkpoint

**Date:** June 18, 2025  
**Branch:** teirv-implementation  
**Status:** Phase 3 - Clinical Data Integration (Ready to Begin)

## Implementation Progress

### ‚úÖ **Phase 1: Core TEIRV Simulator (COMPLETE)**
- **Gillespie Algorithm:** 7-reaction TEIRV stochastic simulation implemented
- **Parameter Handling:** 6 inferred parameters + 2 fixed parameters correctly handled
- **Prior Distributions:** PyTorch-based TEIRVPrior with proper Uniform and log-Uniform distributions
- **Observation Model:** RT-PCR observation model with detection limits and Gaussian noise
- **Initial Conditions:** Standard TEIRV initial state with configurable V‚ÇÄ

### ‚úÖ **Phase 2: NPE Pipeline Adaptation (COMPLETE)**
- **Data Generation:** `TEIRVDataGenerator` class for training data generation
- **Neural Architecture:** Adapted NPE networks for 6-parameter, 14-timepoint data
- **Training Pipeline:** Complete NPE training with SBI integration
- **Validation:** Synthetic data validation and posterior recovery testing
- **Performance:** Individual simulations ~0.1-0.5s, suitable for training

### üîÑ **Phase 3: Clinical Data Integration (IN PROGRESS)**

#### ‚úÖ **Completed Components:**
- **Clinical Data Available:** 6 patient RT-PCR datasets from JSFGermano2024 repository
  - Located in: `external/JSFGermano2024/TEIVR_Results/particle-filter-example-tiv_covid/data/`
  - Format: `.ssv` files with time-value pairs
  - Patients: 432192, 443108, 444332, 444391, 445602, 451152
- **Data Loader:** Basic `ClinicalDataLoader` class in `src/LV/clinical_data.py`
- **Trained Models:** High-quality NPE model available at `models/high_quality_npe.pkl`
- **Infrastructure:** All necessary utilities and preprocessing functions

#### ‚ùå **Missing Components:**
- **Patient-Specific Inference Script:** `scripts/fit_clinical_data.py`
- **Clinical Validation:** Comparison with particle filter benchmark results
- **End-to-End Workflow:** Complete clinical analysis pipeline
- **Results Analysis:** Summary statistics and visualization for clinical parameters

### ‚ùå **Phase 4: Performance Optimization (NOT STARTED)**
- JAX implementation was attempted but abandoned due to poor GPU performance for Gillespie algorithms
- Current PyTorch implementation is sufficiently fast for clinical application

## Technical Status

### **Codebase Organization**
```
src/
‚îú‚îÄ‚îÄ LV/                     # Lotka-Volterra components (legacy)
‚îú‚îÄ‚îÄ TEIRV/                  # Main TEIRV implementation
‚îÇ   ‚îú‚îÄ‚îÄ teirv_simulator.py      # Core Gillespie simulator
‚îÇ   ‚îú‚îÄ‚îÄ teirv_data_generation.py # NPE training data pipeline
‚îÇ   ‚îú‚îÄ‚îÄ teirv_inference.py      # NPE training and inference
‚îÇ   ‚îú‚îÄ‚îÄ teirv_utils.py          # Priors, observation model, utilities
‚îÇ   ‚îî‚îÄ‚îÄ legacy/             # Historical implementations + JAX experiments
scripts/
‚îú‚îÄ‚îÄ generate_teirv_data.py  # Training data generation
‚îú‚îÄ‚îÄ train_teirv_npe.py      # NPE model training
‚îî‚îÄ‚îÄ [other production scripts]
tests/
‚îú‚îÄ‚îÄ debug_teirv_performance.py  # Performance testing
‚îú‚îÄ‚îÄ quick_teirv_test.py         # Quick functionality test
‚îú‚îÄ‚îÄ test_teirv_pipeline.py      # Full pipeline test
‚îî‚îÄ‚îÄ test_teirv_simulator.py     # Simulator validation
```

### **Key Achievements**
1. **Modular Architecture:** Clean separation between LV and TEIRV components
2. **Import Structure:** All relative imports correctly configured for modular use
3. **JAX Legacy:** Failed GPU experiments preserved in `TEIRV/legacy/` for posterity
4. **PyTorch Implementation:** Stable, fast, and clinically viable implementation
5. **Clinical Data Integration:** Real patient data available and accessible

### **Recent Fixes**
- **Import Structure:** Fixed all internal TEIRV module imports to use relative imports (`.teirv_*`)
- **Code Organization:** Moved testing scripts to `tests/` directory for better organization
- **JAX Cleanup:** Moved failed JAX implementations to legacy directory

## Next Steps (Phase 3 Completion)

### **Immediate Priority:**
1. **Create Clinical Inference Script** (`scripts/fit_clinical_data.py`)
   - Load trained NPE model
   - Process each of 6 patients
   - Generate parameter posteriors
   - Export results for comparison

2. **Move Clinical Data Loader** 
   - Move from `src/LV/` to `src/TEIRV/` module
   - Update to handle .ssv format properly
   - Add preprocessing for missing values

3. **Validation Pipeline**
   - Compare NPE results vs JSFGermano2024 particle filter results
   - Generate comparison visualizations
   - Validate parameter estimates against literature

4. **End-to-End Workflow**
   - Create `scripts/clinical_workflow.py`
   - Complete pipeline from raw data to final results
   - Summary reporting and visualization

### **Success Criteria for Phase 3:**
- [ ] NPE parameter estimates for all 6 patients
- [ ] Comparison with particle filter benchmark
- [ ] Reasonable parameter values (literature validation)
- [ ] Automated clinical workflow pipeline

## Technical Notes

### **Performance Characteristics:**
- **Single Simulation:** 0.1-0.5 seconds
- **Batch Generation:** Suitable for NPE training
- **Memory Usage:** Manageable for clinical datasets
- **Platform:** CPU-optimized (GPU acceleration abandoned)

### **Data Characteristics:**
- **Patients:** 6 COVID patients with RT-PCR data
- **Observations:** ~14 timepoints per patient
- **Format:** log‚ÇÅ‚ÇÄ viral load with detection limits
- **Noise Model:** Gaussian observation error (œÉ=1.0)

### **Model Characteristics:**
- **Parameters:** 6 inferred [Œ≤, œÄ, Œ¥, œÜ, œÅ, V‚ÇÄ] + 2 fixed [k, c]
- **Priors:** Uniform distributions matching JSFGermano2024 paper
- **Architecture:** NPE with 256 hidden units, 8 coupling transforms
- **Training:** Stable convergence on synthetic data

## Files Modified This Session
- Fixed imports in `src/TEIRV/teirv_data_generation.py`
- Moved testing scripts: `debug_teirv_performance.py`, `quick_teirv_test.py`, `test_teirv_pipeline.py`, `test_teirv_simulator.py`
- Organized legacy JAX implementations in `src/TEIRV/legacy/`

## Risk Assessment
- **Low Risk:** Core implementation is stable and tested
- **Medium Risk:** Clinical validation against particle filter benchmark
- **Low Risk:** Technical implementation for Phase 3 completion

---

**Ready to proceed with Phase 3 clinical inference implementation.**